A new global market
The Life Sciences and the modern Medicine are currently experiencing a dramatic development fueled by the genomic revolution of single-cell genomics. The technological achievement of single-cell RNA sequencing (or short scRNA-seq) allows for the first time in history to analyze the genetic expression of single cells. Insights gained from single-cell genomics will not only revolutionize the landscape of cancer genomics, immunology and whole-organism science . They will also continue to create a new global market of personalized medicine that is estimated to reach more than $5 billion by 2025 . The Comma Soft AG as a strong partner and expert in Data Science and solutions in the field of Artificial Intelligence (AI) is actively taking part in this market. Furthermore, Comma Soft is building bridges between academia and industry and, thus, fosters translation and promotes knowledge transfer across sectors.
With the Scientific Consulting service Comma Soft and FASTGenomics assist and enable institutions and companies to transition into the field of single-cell genomics and into a promising new market of personalized medicine. Depending on your project requirements, we can bring you in contact with sequencing labs as well as academic and pharmaceutical partners. With our single-cell analytics platform FASTGenomics we provide the perfect working space for your research: We offer secure data management and cutting-edge analysis workflows accessible to both experts and non-experts.
In summary, our Scientific Consulting service offers:
- Project planning and design
- Single-cell sequencing and quality control
- Secure data management
- Cutting-edge analytics
- AI-based methods for state-of-the-art analysis
- Enabling non-experts to conduct their own research
- Biological and technical interpretation
- Contact to academic and pharmaceutical partners
Our scientific consultants have successfully managed research and development projects together with large pharmaceutical companies and health care providers. Comma Soft customers include world leading players such as Boehringer Ingelheim, Qiagen and Bayer. We know how to approach challenging projects and how to drive your single-cell research to clinical and marketable success.
“Together, single cell sequencing and artificial intelligence can be considered powerful tools for biomedical research, enabling insights at the highest resolution.”
Dickten et al., Laborjournal, 2019
our academic collaborators
Our scientific expertise is not only rooted in our talented and multi-faceted team based at Comma Soft, but also in our close collaboration with leading researchers in the field. The Schultze lab at the LIMES Institute of the University of Bonn, Germany, has partnered with FASTGenomics since its beginnings and is a strong partner in our Scientific Consulting service. We are also strongly involved in international research projects and networks such as SYSCID, DiscovAIR and LifeTime.
Request a personal consultation for your single-cell genomics project. We would be happy to get in touch and discuss your plans and prospects. No matter what you are aiming for – we have the experts to face your challenge.
 Shapiro, E., Biezuner, T., & Linnarsson, S. (2013). Single-cell sequencing-based technologies will revolutionize whole-organism science. Nature Reviews Genetics, 14(9), 618.
 Global Single Cell Multi-Omics Market – Analysis and Forecast 2019-2025, Research and Markets Report, June 2019